Combination of paroxetine CR and quetiapine for the treatment of refractory generalized anxiety disorder

Trial Profile

Combination of paroxetine CR and quetiapine for the treatment of refractory generalized anxiety disorder

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jun 2014

At a glance

  • Drugs Quetiapine (Primary) ; Paroxetine
  • Indications Generalised anxiety disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top